Considerable developments in prostate cancer in 2013 have emerged from the imaging field. Hyperpolarized 13C-MRI can monitor metabolic activity to identify high-grade disease and treatment response, and novel PET radiotracers might identify distinct subsets of patients with advanced disease. These examples highlight the progress made at all stages of care.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Puech, P. et al. Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study. Radiology 268, 461–469 (2013).
Cooperberg, M. R. et al. Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort. J. Clin. Oncol. 31, 1428–1434 (2013).
Turkbey, B. et al. Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology 268, 144–152 (2013).
Nelson, S. J. et al. Metabolic imaging of patients with prostate cancer using hyperpolarized [1-13C]pyruvate. Sci. Transl. Med. 5, 198ra108 (2013).
Evangelista, L. et al. Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis. Clin. Nucl. Med. 38, 305–314 (2013).
Beheshti, M., Langsteger, W. & Fogelman, I. Prostate cancer: role of SPECT and PET in imaging bone metastases. Semin. Nucl Med. 39, 396–407 (2009).
Mosquera, J. M. et al. Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer. Neoplasia 15, 1–10 (2013).
Jadvar, H. Molecular imaging of prostate cancer with PET. J. Nucl. Med. 54, 1685–1688 (2013).
Osborne, J. R. et al. A prospective pilot study of 89Zr-J591/PSMA positron emission tomography (PET) in men with localized prostate cancer undergoing radical prostatectomy. J. Urol. http://dx.doi.org/10.1016/j.juro.2013.10.041.
Walia, G., Pienta, K. J., Simons, J. W. & Soule, H. R. The 19th annual Prostate Cancer Foundation scientific retreat. Cancer Res. 73, 4988–4991 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Aggarwal, R., Kurhanewicz, J. The changing role of imaging in clinical care. Nat Rev Urol 11, 75–77 (2014). https://doi.org/10.1038/nrurol.2013.319
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2013.319